The	O
role	O
of	O
miR-451	B:C2603907
in	O
the	O
switching	O
between	O
proliferation	O
and	O
migration	O
in	O
malignant	O
glioma	I:C0555198
cells	O
:	O
AMPK	O
signaling	O
,	O
mTOR	O
modulation	O
and	O
Rac1	O
activation	O
required	O
.	O

The	O
role	O
of	O
miR-451	O
in	O
the	O
switching	O
between	O
proliferation	O
and	O
migration	B:C1533574
in	O
malignant	O
glioma	I:C0555198
cells	O
:	O
AMPK	O
signaling	O
,	O
mTOR	O
modulation	O
and	O
Rac1	O
activation	O
required	O
.	O

The	O
role	O
of	O
miR-451	O
in	O
the	O
switching	O
between	O
proliferation	O
and	O
migration	O
in	O
malignant	B:C0555198
glioma	I:C0555198
cells	O
:	O
AMPK	O
signaling	O
,	O
mTOR	O
modulation	O
and	O
Rac1	O
activation	O
required	O
.	O

The	O
role	O
of	O
miR-451	O
in	O
the	O
switching	O
between	O
proliferation	O
and	O
migration	O
in	O
malignant	O
glioma	I:C0555198
cells	B:C0007634
:	O
AMPK	O
signaling	O
,	O
mTOR	O
modulation	O
and	O
Rac1	O
activation	O
required	O
.	O

The	O
role	O
of	O
miR-451	O
in	O
the	O
switching	O
between	O
proliferation	O
and	O
migration	O
in	O
malignant	O
glioma	I:C0555198
cells	O
:	O
AMPK	B:C0252214
signaling	O
,	O
mTOR	O
modulation	O
and	O
Rac1	O
activation	O
required	O
.	O

The	O
role	O
of	O
miR-451	O
in	O
the	O
switching	O
between	O
proliferation	O
and	O
migration	O
in	O
malignant	O
glioma	I:C0555198
cells	O
:	O
AMPK	O
signaling	B:C3537152
,	O
mTOR	O
modulation	O
and	O
Rac1	O
activation	O
required	O
.	O

The	O
role	O
of	O
miR-451	O
in	O
the	O
switching	O
between	O
proliferation	O
and	O
migration	O
in	O
malignant	O
glioma	I:C0555198
cells	O
:	O
AMPK	O
signaling	O
,	O
mTOR	B:C1307407
modulation	O
and	O
Rac1	O
activation	O
required	O
.	O

The	O
role	O
of	O
miR-451	O
in	O
the	O
switching	O
between	O
proliferation	O
and	O
migration	O
in	O
malignant	O
glioma	I:C0555198
cells	O
:	O
AMPK	O
signaling	O
,	O
mTOR	O
modulation	B:C0443264
and	O
Rac1	O
activation	O
required	O
.	O

The	O
role	O
of	O
miR-451	O
in	O
the	O
switching	O
between	O
proliferation	O
and	O
migration	O
in	O
malignant	O
glioma	I:C0555198
cells	O
:	O
AMPK	O
signaling	O
,	O
mTOR	O
modulation	O
and	O
Rac1	B:C0139880
activation	O
required	O
.	O

Glioblastoma	B:C1621958
multiforme	I:C1621958
(	O
Glioblastoma	O
multiforme	I:C1621958
)	O
,	O
WHO	O
grade	I:C0017636
IV	I:C0017636
astrocytoma	I:C0017636
,	O
is	O
the	O
most	O
common	O
primary	O
neoplasm	I:C0677930
of	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
and	O
has	O
the	O
highest	O
malignancy	O
and	O
mortality	O
rates	O
.	O

Glioblastoma	O
multiforme	I:C1621958
(	O
Glioblastoma	B:C1621958
multiforme	I:C1621958
)	O
,	O
WHO	O
grade	I:C0017636
IV	I:C0017636
astrocytoma	I:C0017636
,	O
is	O
the	O
most	O
common	O
primary	O
neoplasm	I:C0677930
of	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
and	O
has	O
the	O
highest	O
malignancy	O
and	O
mortality	O
rates	O
.	O

Glioblastoma	O
multiforme	I:C1621958
(	O
Glioblastoma	O
multiforme	I:C1621958
)	O
,	O
WHO	B:C0017636
grade	I:C0017636
IV	I:C0017636
astrocytoma	I:C0017636
,	O
is	O
the	O
most	O
common	O
primary	O
neoplasm	I:C0677930
of	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
and	O
has	O
the	O
highest	O
malignancy	O
and	O
mortality	O
rates	O
.	O

Glioblastoma	O
multiforme	I:C1621958
(	O
Glioblastoma	O
multiforme	I:C1621958
)	O
,	O
WHO	O
grade	I:C0017636
IV	I:C0017636
astrocytoma	I:C0017636
,	O
is	O
the	O
most	O
common	O
primary	B:C0677930
neoplasm	I:C0677930
of	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
and	O
has	O
the	O
highest	O
malignancy	O
and	O
mortality	O
rates	O
.	O

Glioblastoma	O
multiforme	I:C1621958
(	O
Glioblastoma	O
multiforme	I:C1621958
)	O
,	O
WHO	O
grade	I:C0017636
IV	I:C0017636
astrocytoma	I:C0017636
,	O
is	O
the	O
most	O
common	O
primary	O
neoplasm	I:C0677930
of	O
the	O
central	B:C3714787
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
and	O
has	O
the	O
highest	O
malignancy	O
and	O
mortality	O
rates	O
.	O

Glioblastoma	O
multiforme	I:C1621958
(	O
Glioblastoma	O
multiforme	I:C1621958
)	O
,	O
WHO	O
grade	I:C0017636
IV	I:C0017636
astrocytoma	I:C0017636
,	O
is	O
the	O
most	O
common	O
primary	O
neoplasm	I:C0677930
of	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	B:C3714787
nervous	I:C3714787
system	I:C3714787
)	O
and	O
has	O
the	O
highest	O
malignancy	O
and	O
mortality	O
rates	O
.	O

Glioblastoma	O
multiforme	I:C1621958
(	O
Glioblastoma	O
multiforme	I:C1621958
)	O
,	O
WHO	O
grade	I:C0017636
IV	I:C0017636
astrocytoma	I:C0017636
,	O
is	O
the	O
most	O
common	O
primary	O
neoplasm	I:C0677930
of	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
and	O
has	O
the	O
highest	O
malignancy	B:C4282132
and	O
mortality	O
rates	O
.	O

The	O
invasive	O
nature	O
of	O
Glioblastoma	B:C1621958
multiforme	I:C1621958
complicates	O
surgical	O
resection	I:C0728940
and	O
restricts	O
chemotherapeutic	O
access	O
,	O
contributing	O
to	O
poor	O
patient	O
prognosis	O
.	O

The	O
invasive	O
nature	O
of	O
Glioblastoma	O
multiforme	I:C1621958
complicates	O
surgical	B:C0728940
resection	I:C0728940
and	O
restricts	O
chemotherapeutic	O
access	O
,	O
contributing	O
to	O
poor	O
patient	O
prognosis	O
.	O

The	O
invasive	O
nature	O
of	O
Glioblastoma	O
multiforme	I:C1621958
complicates	O
surgical	O
resection	I:C0728940
and	O
restricts	O
chemotherapeutic	O
access	O
,	O
contributing	O
to	O
poor	O
patient	O
prognosis	B:C0033325
.	O

The	O
migration	B:C1533574
of	O
tumor	O
cells	I:C0597032
is	O
closely	O
related	O
to	O
the	O
tumor	O
cell	I:C0597032
proliferation	O
.	O

The	O
migration	O
of	O
tumor	B:C0597032
cells	I:C0597032
is	O
closely	O
related	O
to	O
the	O
tumor	O
cell	I:C0597032
proliferation	O
.	O

The	O
migration	O
of	O
tumor	O
cells	I:C0597032
is	O
closely	O
related	O
to	O
the	O
tumor	B:C0597032
cell	I:C0597032
proliferation	O
.	O

The	O
acquisition	O
of	O
migratory	O
capability	O
,	O
in	O
addition	O
to	O
intracellular	B:C0178719
factors	O
,	O
is	O
proposed	O
to	O
be	O
a	O
crucial	O
mechanism	O
during	O
the	O
progression	O
of	O
invasion	O
.	O

The	O
acquisition	O
of	O
migratory	O
capability	O
,	O
in	O
addition	O
to	O
intracellular	O
factors	O
,	O
is	O
proposed	O
to	O
be	O
a	O
crucial	O
mechanism	O
during	O
the	O
progression	O
of	O
invasion	B:C1269955
.	O

Using	O
qRT	B:C1514628
-PCR	I:C1514628
analysis	O
,	O
we	O
determined	O
that	O
the	O
expression	O
of	O
miR-451	O
in	O
glioma	O
tissue	O
was	O
lower	O
than	O
in	O
control	O
brain	I:C0459385
tissue	I:C0459385
,	O
especially	O
in	O
the	O
central	O
portions	O
of	O
the	O
tumor	O
.	O

Using	O
qRT	O
-PCR	I:C1514628
analysis	B:C0936012
,	O
we	O
determined	O
that	O
the	O
expression	O
of	O
miR-451	O
in	O
glioma	O
tissue	O
was	O
lower	O
than	O
in	O
control	O
brain	I:C0459385
tissue	I:C0459385
,	O
especially	O
in	O
the	O
central	O
portions	O
of	O
the	O
tumor	O
.	O

Using	O
qRT	O
-PCR	I:C1514628
analysis	O
,	O
we	O
determined	O
that	O
the	O
expression	B:C0017262
of	O
miR-451	O
in	O
glioma	O
tissue	O
was	O
lower	O
than	O
in	O
control	O
brain	I:C0459385
tissue	I:C0459385
,	O
especially	O
in	O
the	O
central	O
portions	O
of	O
the	O
tumor	O
.	O

Using	O
qRT	O
-PCR	I:C1514628
analysis	O
,	O
we	O
determined	O
that	O
the	O
expression	O
of	O
miR-451	B:C1826031
in	O
glioma	O
tissue	O
was	O
lower	O
than	O
in	O
control	O
brain	I:C0459385
tissue	I:C0459385
,	O
especially	O
in	O
the	O
central	O
portions	O
of	O
the	O
tumor	O
.	O

Using	O
qRT	O
-PCR	I:C1514628
analysis	O
,	O
we	O
determined	O
that	O
the	O
expression	O
of	O
miR-451	O
in	O
glioma	B:C0017638
tissue	O
was	O
lower	O
than	O
in	O
control	O
brain	I:C0459385
tissue	I:C0459385
,	O
especially	O
in	O
the	O
central	O
portions	O
of	O
the	O
tumor	O
.	O

Using	O
qRT	O
-PCR	I:C1514628
analysis	O
,	O
we	O
determined	O
that	O
the	O
expression	O
of	O
miR-451	O
in	O
glioma	O
tissue	B:C0040300
was	O
lower	O
than	O
in	O
control	O
brain	I:C0459385
tissue	I:C0459385
,	O
especially	O
in	O
the	O
central	O
portions	O
of	O
the	O
tumor	O
.	O

Using	O
qRT	O
-PCR	I:C1514628
analysis	O
,	O
we	O
determined	O
that	O
the	O
expression	O
of	O
miR-451	O
in	O
glioma	O
tissue	O
was	O
lower	O
than	O
in	O
control	B:C0459385
brain	I:C0459385
tissue	I:C0459385
,	O
especially	O
in	O
the	O
central	O
portions	O
of	O
the	O
tumor	O
.	O

Using	O
qRT	O
-PCR	I:C1514628
analysis	O
,	O
we	O
determined	O
that	O
the	O
expression	O
of	O
miR-451	O
in	O
glioma	O
tissue	O
was	O
lower	O
than	O
in	O
control	O
brain	I:C0459385
tissue	I:C0459385
,	O
especially	O
in	O
the	O
central	B:C0205099
portions	O
of	O
the	O
tumor	O
.	O

Using	O
qRT	O
-PCR	I:C1514628
analysis	O
,	O
we	O
determined	O
that	O
the	O
expression	O
of	O
miR-451	O
in	O
glioma	O
tissue	O
was	O
lower	O
than	O
in	O
control	O
brain	I:C0459385
tissue	I:C0459385
,	O
especially	O
in	O
the	O
central	O
portions	B:C0449719
of	O
the	O
tumor	O
.	O

Using	O
qRT	O
-PCR	I:C1514628
analysis	O
,	O
we	O
determined	O
that	O
the	O
expression	O
of	O
miR-451	O
in	O
glioma	O
tissue	O
was	O
lower	O
than	O
in	O
control	O
brain	I:C0459385
tissue	I:C0459385
,	O
especially	O
in	O
the	O
central	O
portions	O
of	O
the	O
tumor	B:C0027651
.	O

In	O
glioma	B:C0017638
cell	O
lines	I:C0085983
,	O
we	O
found	O
that	O
decreased	O
miR-451	O
expression	O
suppressed	O
tumor	O
cell	I:C0597032
proliferation	O
but	O
enhanced	O
migration	O
with	O
a	O
concomitant	O
low	O
level	O
of	O
CAB39	O
/	O
AMPK	O
/	O
mTOR	O
pathway	O
activation	O
and	O
high	O
level	O
of	O
Rac1	O
/	O
cofilin	O
pathway	O
activation	O
,	O
respectively	O
.	O

In	O
glioma	O
cell	B:C0085983
lines	I:C0085983
,	O
we	O
found	O
that	O
decreased	O
miR-451	O
expression	O
suppressed	O
tumor	O
cell	I:C0597032
proliferation	O
but	O
enhanced	O
migration	O
with	O
a	O
concomitant	O
low	O
level	O
of	O
CAB39	O
/	O
AMPK	O
/	O
mTOR	O
pathway	O
activation	O
and	O
high	O
level	O
of	O
Rac1	O
/	O
cofilin	O
pathway	O
activation	O
,	O
respectively	O
.	O

In	O
glioma	O
cell	O
lines	I:C0085983
,	O
we	O
found	O
that	O
decreased	O
miR-451	B:C1826031
expression	O
suppressed	O
tumor	O
cell	I:C0597032
proliferation	O
but	O
enhanced	O
migration	O
with	O
a	O
concomitant	O
low	O
level	O
of	O
CAB39	O
/	O
AMPK	O
/	O
mTOR	O
pathway	O
activation	O
and	O
high	O
level	O
of	O
Rac1	O
/	O
cofilin	O
pathway	O
activation	O
,	O
respectively	O
.	O

In	O
glioma	O
cell	O
lines	I:C0085983
,	O
we	O
found	O
that	O
decreased	O
miR-451	O
expression	B:C0017262
suppressed	O
tumor	O
cell	I:C0597032
proliferation	O
but	O
enhanced	O
migration	O
with	O
a	O
concomitant	O
low	O
level	O
of	O
CAB39	O
/	O
AMPK	O
/	O
mTOR	O
pathway	O
activation	O
and	O
high	O
level	O
of	O
Rac1	O
/	O
cofilin	O
pathway	O
activation	O
,	O
respectively	O
.	O

In	O
glioma	O
cell	O
lines	I:C0085983
,	O
we	O
found	O
that	O
decreased	O
miR-451	O
expression	O
suppressed	O
tumor	B:C0597032
cell	I:C0597032
proliferation	O
but	O
enhanced	O
migration	O
with	O
a	O
concomitant	O
low	O
level	O
of	O
CAB39	O
/	O
AMPK	O
/	O
mTOR	O
pathway	O
activation	O
and	O
high	O
level	O
of	O
Rac1	O
/	O
cofilin	O
pathway	O
activation	O
,	O
respectively	O
.	O

In	O
glioma	O
cell	O
lines	I:C0085983
,	O
we	O
found	O
that	O
decreased	O
miR-451	O
expression	O
suppressed	O
tumor	O
cell	I:C0597032
proliferation	O
but	O
enhanced	O
migration	B:C1533574
with	O
a	O
concomitant	O
low	O
level	O
of	O
CAB39	O
/	O
AMPK	O
/	O
mTOR	O
pathway	O
activation	O
and	O
high	O
level	O
of	O
Rac1	O
/	O
cofilin	O
pathway	O
activation	O
,	O
respectively	O
.	O

In	O
glioma	O
cell	O
lines	I:C0085983
,	O
we	O
found	O
that	O
decreased	O
miR-451	O
expression	O
suppressed	O
tumor	O
cell	I:C0597032
proliferation	O
but	O
enhanced	O
migration	O
with	O
a	O
concomitant	O
low	O
level	O
of	O
CAB39	B:C2715759
/	O
AMPK	O
/	O
mTOR	O
pathway	O
activation	O
and	O
high	O
level	O
of	O
Rac1	O
/	O
cofilin	O
pathway	O
activation	O
,	O
respectively	O
.	O

In	O
glioma	O
cell	O
lines	I:C0085983
,	O
we	O
found	O
that	O
decreased	O
miR-451	O
expression	O
suppressed	O
tumor	O
cell	I:C0597032
proliferation	O
but	O
enhanced	O
migration	O
with	O
a	O
concomitant	O
low	O
level	O
of	O
CAB39	O
/	O
AMPK	B:C0252214
/	O
mTOR	O
pathway	O
activation	O
and	O
high	O
level	O
of	O
Rac1	O
/	O
cofilin	O
pathway	O
activation	O
,	O
respectively	O
.	O

In	O
glioma	O
cell	O
lines	I:C0085983
,	O
we	O
found	O
that	O
decreased	O
miR-451	O
expression	O
suppressed	O
tumor	O
cell	I:C0597032
proliferation	O
but	O
enhanced	O
migration	O
with	O
a	O
concomitant	O
low	O
level	O
of	O
CAB39	O
/	O
AMPK	O
/	O
mTOR	B:C1307407
pathway	O
activation	O
and	O
high	O
level	O
of	O
Rac1	O
/	O
cofilin	O
pathway	O
activation	O
,	O
respectively	O
.	O

In	O
glioma	O
cell	O
lines	I:C0085983
,	O
we	O
found	O
that	O
decreased	O
miR-451	O
expression	O
suppressed	O
tumor	O
cell	I:C0597032
proliferation	O
but	O
enhanced	O
migration	O
with	O
a	O
concomitant	O
low	O
level	O
of	O
CAB39	O
/	O
AMPK	O
/	O
mTOR	O
pathway	O
activation	O
and	O
high	O
level	O
of	O
Rac1	B:C0139880
/	O
cofilin	O
pathway	O
activation	O
,	O
respectively	O
.	O

Notably	O
,	O
the	O
effect	O
of	O
miR-451	B:C2603907
on	O
cytological	O
behavior	O
and	O
on	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	O
was	O
limited	O
when	O
AMPKα1	O
expression	O
was	O
knocked	O
-	O
down	O
with	O
a	O
synthetic	O
shRNA	O
.	O

Notably	O
,	O
the	O
effect	O
of	O
miR-451	O
on	O
cytological	O
behavior	O
and	O
on	O
the	O
activation	O
of	O
mTOR	B:C1307407
and	O
Rac1	O
was	O
limited	O
when	O
AMPKα1	O
expression	O
was	O
knocked	O
-	O
down	O
with	O
a	O
synthetic	O
shRNA	O
.	O

Notably	O
,	O
the	O
effect	O
of	O
miR-451	O
on	O
cytological	O
behavior	O
and	O
on	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	B:C0139880
was	O
limited	O
when	O
AMPKα1	O
expression	O
was	O
knocked	O
-	O
down	O
with	O
a	O
synthetic	O
shRNA	O
.	O

Notably	O
,	O
the	O
effect	O
of	O
miR-451	O
on	O
cytological	O
behavior	O
and	O
on	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	O
was	O
limited	O
when	O
AMPKα1	B:C1739697
expression	O
was	O
knocked	O
-	O
down	O
with	O
a	O
synthetic	O
shRNA	O
.	O

Notably	O
,	O
the	O
effect	O
of	O
miR-451	O
on	O
cytological	O
behavior	O
and	O
on	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	O
was	O
limited	O
when	O
AMPKα1	O
expression	B:C1171362
was	O
knocked	O
-	O
down	O
with	O
a	O
synthetic	O
shRNA	O
.	O

Notably	O
,	O
the	O
effect	O
of	O
miR-451	O
on	O
cytological	O
behavior	O
and	O
on	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	O
was	O
limited	O
when	O
AMPKα1	O
expression	O
was	O
knocked	O
-	O
down	O
with	O
a	O
synthetic	O
shRNA	B:C2930586
.	O

We	O
suggest	O
that	O
the	O
glioma	B:C0017638
microenvironment	O
results	O
in	O
heterogeneity	O
of	O
miR-451	O
expression	O
.	O

We	O
suggest	O
that	O
the	O
glioma	O
microenvironment	O
results	O
in	O
heterogeneity	O
of	O
miR-451	B:C1826031
expression	O
.	O

We	O
suggest	O
that	O
the	O
glioma	O
microenvironment	O
results	O
in	O
heterogeneity	O
of	O
miR-451	O
expression	B:C0017262
.	O

Our	O
data	O
indicated	O
that	O
miR-451	B:C2603907
relays	O
environmental	O
signals	O
by	O
upregulating	O
the	O
activity	O
of	O
AMPK	O
signaling	O
,	O
thereby	O
modulating	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	O
/	O
cofilin	O
which	O
,	O
in	O
turn	O
,	O
play	O
key	O
roles	O
in	O
glioma	O
cell	O
proliferation	O
and	O
migration	O
,	O
respectively	O
.	O

Our	O
data	O
indicated	O
that	O
miR-451	O
relays	O
environmental	O
signals	O
by	O
upregulating	B:C0041904
the	O
activity	O
of	O
AMPK	O
signaling	O
,	O
thereby	O
modulating	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	O
/	O
cofilin	O
which	O
,	O
in	O
turn	O
,	O
play	O
key	O
roles	O
in	O
glioma	O
cell	O
proliferation	O
and	O
migration	O
,	O
respectively	O
.	O

Our	O
data	O
indicated	O
that	O
miR-451	O
relays	O
environmental	O
signals	O
by	O
upregulating	O
the	O
activity	O
of	O
AMPK	B:C0252214
signaling	O
,	O
thereby	O
modulating	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	O
/	O
cofilin	O
which	O
,	O
in	O
turn	O
,	O
play	O
key	O
roles	O
in	O
glioma	O
cell	O
proliferation	O
and	O
migration	O
,	O
respectively	O
.	O

Our	O
data	O
indicated	O
that	O
miR-451	O
relays	O
environmental	O
signals	O
by	O
upregulating	O
the	O
activity	O
of	O
AMPK	O
signaling	B:C3537152
,	O
thereby	O
modulating	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	O
/	O
cofilin	O
which	O
,	O
in	O
turn	O
,	O
play	O
key	O
roles	O
in	O
glioma	O
cell	O
proliferation	O
and	O
migration	O
,	O
respectively	O
.	O

Our	O
data	O
indicated	O
that	O
miR-451	O
relays	O
environmental	O
signals	O
by	O
upregulating	O
the	O
activity	O
of	O
AMPK	O
signaling	O
,	O
thereby	O
modulating	B:C0443264
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	O
/	O
cofilin	O
which	O
,	O
in	O
turn	O
,	O
play	O
key	O
roles	O
in	O
glioma	O
cell	O
proliferation	O
and	O
migration	O
,	O
respectively	O
.	O

Our	O
data	O
indicated	O
that	O
miR-451	O
relays	O
environmental	O
signals	O
by	O
upregulating	O
the	O
activity	O
of	O
AMPK	O
signaling	O
,	O
thereby	O
modulating	O
the	O
activation	O
of	O
mTOR	B:C1307407
and	O
Rac1	O
/	O
cofilin	O
which	O
,	O
in	O
turn	O
,	O
play	O
key	O
roles	O
in	O
glioma	O
cell	O
proliferation	O
and	O
migration	O
,	O
respectively	O
.	O

Our	O
data	O
indicated	O
that	O
miR-451	O
relays	O
environmental	O
signals	O
by	O
upregulating	O
the	O
activity	O
of	O
AMPK	O
signaling	O
,	O
thereby	O
modulating	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	B:C0139880
/	O
cofilin	O
which	O
,	O
in	O
turn	O
,	O
play	O
key	O
roles	O
in	O
glioma	O
cell	O
proliferation	O
and	O
migration	O
,	O
respectively	O
.	O

Our	O
data	O
indicated	O
that	O
miR-451	O
relays	O
environmental	O
signals	O
by	O
upregulating	O
the	O
activity	O
of	O
AMPK	O
signaling	O
,	O
thereby	O
modulating	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	O
/	O
cofilin	O
which	O
,	O
in	O
turn	O
,	O
play	O
key	O
roles	O
in	O
glioma	B:C0017638
cell	O
proliferation	O
and	O
migration	O
,	O
respectively	O
.	O

Our	O
data	O
indicated	O
that	O
miR-451	O
relays	O
environmental	O
signals	O
by	O
upregulating	O
the	O
activity	O
of	O
AMPK	O
signaling	O
,	O
thereby	O
modulating	O
the	O
activation	O
of	O
mTOR	O
and	O
Rac1	O
/	O
cofilin	O
which	O
,	O
in	O
turn	O
,	O
play	O
key	O
roles	O
in	O
glioma	O
cell	O
proliferation	O
and	O
migration	B:C1533574
,	O
respectively	O
.	O

Our	O
results	O
highlight	O
the	O
need	O
to	O
consider	O
opposing	O
roles	O
of	O
a	O
therapeutic	O
target	O
which	O
,	O
while	O
suppressing	O
tumor	B:C0597032
cell	I:C0597032
proliferation	O
,	O
could	O
also	O
promote	O
cell	O
infiltration	O
.	O

Our	O
results	O
highlight	O
the	O
need	O
to	O
consider	O
opposing	O
roles	O
of	O
a	O
therapeutic	O
target	O
which	O
,	O
while	O
suppressing	O
tumor	O
cell	I:C0597032
proliferation	O
,	O
could	O
also	O
promote	O
cell	B:C0007634
infiltration	O
.	O

Our	O
results	O
highlight	O
the	O
need	O
to	O
consider	O
opposing	O
roles	O
of	O
a	O
therapeutic	O
target	O
which	O
,	O
while	O
suppressing	O
tumor	O
cell	I:C0597032
proliferation	O
,	O
could	O
also	O
promote	O
cell	O
infiltration	B:C0332448
.	O

